Literature DB >> 8592631

RP67580, a neurokinin1 receptor antagonist, decreased restraint stress-induced defecation in rat.

K Ikeda1, K Miyata, A Orita, H Kubota, T Yamada, K Tomioka.   

Abstract

We investigated the possibility that substance P would mediate defecation in rats subjected to restraint-stress. The increases in fecal pellet output caused by restraint-stress were inhibited by a neurokinin (NK)1 receptor antagonist, RP67580 with an ED50 (95% confidence limits) value of 0.59 (0.54-0.65) mg/kg i.p. RP68651, the enantiomer of RP67580 devoid of affinity for NK1 receptors, had little effect on it. In contrast, (+/-)SR48968, an NK2 receptor antagonist, was without effect. Furthermore, capsaicin treatment (125 mg/kg i.p.) was inactive in this model. These results suggest that the activation of NK1 receptors and substance P released from intrinsic neurons of the colon would be involved in stress-induced defecation in rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592631     DOI: 10.1016/0304-3940(95)11972-y

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Regional variations in neurokinin receptor subtype contributions to muscularis mucosae and epithelial function in rat colon.

Authors:  Caroline B Appleyard; Marangelie Morales; William H Percy
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

2.  Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome.

Authors:  Jun-Ho La; Tae-Wan Kim; Tae-Sik Sung; Hyn-Ju Kim; Jeom-Yong Kim; Il-Suk Yang
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

3.  Acute restraint stress activates functional NK1 receptor in the colon of female rats: involvement of steroids.

Authors:  S Bradesi; H Eutamene; J Fioramonti; L Bueno
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

Review 4.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.